Eric J Hagen

USPTO Granted Patents = 13 (Patent Applications = 6)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

Euthymics Bioscience, Inc.

patents

3 out of 43

Cymabay Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2009-2017

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9845285 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2017-12-19),

2. 9770436 - Polymorphs of azabicyclohexane (2017-09-26),

3. 9624271 - Romidepsin solid forms and uses thereof (2017-04-18),

4. 9518094 - Romidepsin solid forms and uses thereof (2016-12-13),

5. 9233914 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2016-01-12),

6. 9139521 - Polymorphs of azabicyclohexane (2015-09-22),

7. 8993797 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2015-03-31),

8. 8980825 - Romidepsin solid forms and uses thereof (2015-03-17),

9. 8765801 - Polymorphs of azabicyclohexane (2014-07-01),

10. 8507719 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2013-08-13),

11. 8203019 - Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto (2012-06-19),

12. 7692038 - Crystalline forms (2010-04-06),

13. 7625918 - Hydrocodone polymorphs (2009-12-01),

Title: Innovations and Contributions of Eric J Hagen

Introduction

Eric J Hagen is a notable inventor based in Lafayette, IN (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Hagen has developed innovative solutions aimed at addressing critical health issues.

Latest Patents

Among his latest patents is the invention of crystalline solid and amorphous forms of (−)-halofenate. This invention provides various pharmaceutical compositions that are particularly effective in preventing and treating conditions associated with blood lipid deposition in mammals, especially diseases related to Type 2 diabetes and hyperlipidemia. Another significant patent involves polymorphs of azabicyclohexane, which includes polymorphic crystalline forms of acid addition salts of (+)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane. This invention highlights polymorph form A, which is more thermodynamically stable than other forms, along with methods for preparing and utilizing these polymorphs in pharmaceutical compositions.

Career Highlights

Hagen has worked with several companies throughout his career, including Diatex, Inc. and Euthymics Bioscience, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Hagen has collaborated with notable coworkers such as Jason A Hanko and Edward D Daugs, further enhancing his contributions to the field.

Conclusion

Eric J Hagen's innovative work and numerous patents reflect his dedication to improving health outcomes through pharmaceutical advancements. His contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

6 patents pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.